Ceftazidime–avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
2023 · Infection · 26 citations
https://doi.org/10.1007/s15010-023-02108-6
P
Pengxiang Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
821
Citations
13
h-index
18
i10-index
Pengxiang Zhou is an academic researcher from Peking University. The author has contributed to research in topics: Antibiotics Pharmacokinetics and Efficacy & Antibiotic Resistance in Bacteria & Pneumonia and Respiratory Infections. The author has an h-index of 13, co-authored 37 publications.
ORCID: 0000-0003-1208-8217Papers by this author
worksIntravenous Parecoxib for Pain Relief after Orthopedic Surgery: A Systematic Review and Meta-analysis
2022 · Pain and Therapy · 11 citations
https://doi.org/10.1007/s40122-022-00400-1
Mortality-related risk factors of carbapenem-resistant Enterobacteriaceae infection with focus on antimicrobial regimens optimization: a real-world retrospective study in China
2025 · BMC Infectious Diseases · 6 citations
https://doi.org/10.1186/s12879-025-10454-z
The integration of hospital pharmacists into primary care settings in Shenzhen, China: a qualitative study
2025 · BMC Health Services Research · 2 citations
https://doi.org/10.1186/s12913-025-12351-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat